Prostate cancer screening parameters in a high-risk African-Caribbean population

Urology

Volumn 63, Issue 4, 2004, Pages 737-741

  Bunker, Clareann H ^a   Patrick, Alan L ^b   Miljkovic Gacic, Iva ^b   Konety, Badrinath R ^b   Belle, Andrew ^b   Richard, Jean Robert ^b   Dhir, Rajiv ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AFRICAN CARIBBEAN; AGED; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIGITAL RECTUM EXAMINATION; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PARAMETER; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL ANALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PALPATION; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRINIDAD AND TOBAGO;

EID: 1842739189     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.10.064     Document Type: Article

References (22)

1. Edwards B., Howe H., Ries L., et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 94:2002;2766-2792.
2. Glover F., Coffey D., Douglas L., et al. The epidemiology of prostate cancer in Jamaica. J Urol. 159:1998;1984-1987.
3. Smith R., Cokkinides V., Von Eschenbach A., et al. American Cancer Society guidelines for the early detection of cancer (2002). CA Cancer J Clin. 52:2002;8-22.
4. Moul J.W., Sesterhenn I.A., Connelly R.R., et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 274:1995;1277-1281.
5. Morgan T.O., Jacobsen S.J., McCarthy W.F., et al. Age-specific reference ranges for serum prostate-specific antigen in black men. N Engl J Med. 335:1996;304-310.
6. Asbell S.O., Vijayakumar S. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Prostate. 31:1997;42-46.
7. Sakr WA, Haas GP, Gassin BF, et al: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150(2 Pt 1): 379-385, 1993
8. Sakr W.A., Crignon D.J., Haas G.P. Epidemiology of high-grade prostatic intraepithelial neoplasia. Pathol Res Pract. 191:1995;838-841.
9. Ross R.K., Bernstein L., Lobo R.A., et al. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 339:1992;887-889.
10. Smith D.S., Bullock A.D., Catalona W.J. Racial differences in operating characteristics of prostate cancer screening tests. J Urol. 158:1997;1861-1865.
11. Powell I.J., Heilbrun L., Culkin P.L., et al. Outcome of African American men screened for prostate cancer the Detroit Education and Early Detection study. J Urol. 158:1997;146-149.
12. Central Statistical Office, Office of the Prime Minister, Republic of Trinidad and Tobago: 1990 Population and Housing Census, vol 11: Demographic Report: Age Structure, Religion, Ethnic Group. Education. Port of Spain, Trinidad and Tobago, Office of the Prime Minister, Central Statistical Office, 1993, pp 4-5
13. Prorok P.C., Andriole G.L., Bresalier R.S., et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 21:2000;273S-309S.
14. Punglia R.S., D'Amico A.V., Catalona W.J., et al. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med. 394:2003;335-342.
15. Richie J.P., Catalona W.J., Ahmann F.R., et al. Effect of patient age on early detection of prostate cancer with serum prostate specific antigen and digital rectal examination. Urology. 42:1993;365-374.
16. Smith D.S., Carvalhal G.F., Mager D.E., et al. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol. 160:1998;1734-1738.
17. Bunker C.H., Patrick A.L., Konety B.R., et al. High prevalence of screening-detected prostate cancer among Afro-Caribbeans the Tobago Prostate Survey. Cancer Epidemiol Biomark Prev. 11:2002;726-729.
18. Catalona W.J., Antenor J.A.V., Roehl K.A. Screening for prostate cancer in high risk populations. J Urol. 168:2002;1980-1984.
19. Crawford E.D., Leewansangtong S., Goktas S., et al. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/mL and age-specific reference range as a cutoff for abnormal values. Prostate. 38:1999;296-302.
20. Carvalhal G.F., Smith D.S., Mager D.E., et al. Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng/mL or less. J Urol. 161:1999;835-839.
21. Roberts R.O., Bergstralh E.J., Lieber M.M., et al. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsies and biopsy outcomes, 1980 to 1997. Urology. 56:2000;817-822.
22. Fowler J.E. Jr, Bigler S.A., Farabaugh P.B., et al. Prostate cancer detection in black and white men with abnormal digital rectal examination and prostate specific antigen less than 4 ng/ml. J Urol. 164:2000;1961-1963.